Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Early action required for prevention, management of fatty liver in type 2 diabetes
-
- VIDEO: Exposure to common chemicals may lead to obesity, diabetes
- FDA advisory committee rejects recommending approval of lower-dose empagliflozin for type 1 diabetes
- Work together to achieve wellness goals of people living with diabetes Susan Weiner, MS, RDN, CDN, CDCES, FADCES
- To fight frailty, target endocrine ‘stress response system’
- Adrenal insufficiency increases ICU admission, prolongs hospital stay
- Estrogen exposure influences cognitive status in late life
- Greater renal benefits seen with bariatric surgery vs. medications in pediatric type 2 diabetes, obesity
- Hypertriglyceridemia affects nearly 20% of adults with diabetes despite statin use
-
- Oral blood cancer drug may worsen cardiometabolic health
- Calculator uses AI to estimate 10-year risks for diabetes complications after bariatric surgery
- Drug strengths, stability of compounded levothyroxine suspensions vary widely
- Intermittent fasting research still developing, time-restricted feeding shows potential
- Meal size advice helps parents choose healthier options for children at restaurants
- Pediatric obesity still seen as a result of ‘bad habits’
- Researcher highlights new treatments for thyroid eye disease
- Thyroid over-replacement may increase atrial fibrillation, stroke risks Jill Rollet
-
- What is the best way to screen very high-risk patients for fatty liver or fibrosis?